Mark Savaya’s Leaf & Bud Enhances Medicinal Cannabis Access for Cancer Patients Amidst Growing Research

Mark Savaya, a prominent entrepreneur and founder of the Michigan-based Leaf & Bud dispensaries, is expanding patient-centered programs designed to significantly improve access to medicinal cannabis for individuals battling serious illnesses, particularly cancer. This initiative comes at a time when research increasingly supports cannabis as a complementary therapy for managing cancer-related symptoms, marking a significant…

Read More

Green Thumb Industries to Unveil Q3 2025 Financials Amidst Evolving Cannabis Market Trends

Green Thumb Industries Inc. (GTI), a prominent national cannabis consumer packaged goods company and owner of RISE Dispensaries, has announced it will release its third quarter 2025 financial results after the market closes on Wednesday, November 5, 2025. This announcement comes as the broader U.S. cannabis industry navigates significant trends, including ongoing legalization efforts, evolving…

Read More

The New Wave of Cannabis Marketing: 5 Trends Driving Industry Engagement in 2025

The cannabis industry is experiencing a profound transformation, moving beyond its countercultural roots into a mainstream sector shaped by evolving regulations, consumer expectations, and technological advancements. This dynamic environment demands sophisticated marketing strategies to differentiate brands and foster genuine consumer connections. As the market matures, several key trends are emerging, redefining how cannabis businesses attract,…

Read More

SAP S/4HANA Fuels Trulieve’s Explosive Growth in the Evolving U.S. Cannabis Industry

As the United States cannabis market continues its rapid expansion and evolution, one of its leading players, Trulieve, has turned to enterprise resource planning (ERP) powerhouse SAP to manage its increasingly complex operations. Trulieve, the largest vertically integrated cannabis operator in the U.S., is leveraging SAP S/4HANA and other SAP solutions to gain critical insights…

Read More

Cannabis Supply Shortages Threaten Independent Dispensaries, As Regulatory Hurdles and Cultivation Delays Drag On

Independent cannabis dispensaries across the nation are facing an existential crisis as a persistent recreational cannabis supply shortage, coupled with complex regulatory landscapes, pushes many to the brink of closure. This ongoing issue is a significant trending topic in cannabis news, leaving small business owners struggling to keep their doors open. The Scarcity Crisis: Cultivation,…

Read More

Minnesota Cannabis Businesses Navigate Steep Real Estate Hurdles Amidst Zoning, Landlord Hesitation, and Banking Woes

Licensed cannabis businesses in Minnesota are encountering a complex web of real estate challenges that are significantly impeding their launch and operational growth. From restrictive zoning laws enacted by local governments to cautious landlords and persistent federal banking regulations, entrepreneurs are facing a steep climb to secure suitable and affordable commercial spaces. This challenging landscape…

Read More

Ayr Wellness Charts New Course: Debt Slashed by 50% in Major Restructuring, Securing Future Under New Ownership

A multi-state cannabis operator, Ayr Wellness, is undergoing a profound financial transformation, initiating a comprehensive debt restructuring that aims to cut its outstanding debt by approximately 50% and reposition the company for future growth. This strategic overhaul involves a foreclosure sale of key assets through Article 9 proceedings, marking a pivotal moment for the U.S….

Read More

MJBizCon Spotlights Women Leading Diversity and Innovation in the Booming Cannabis Industry

Las Vegas, NV – The annual MJBizCon, a premier event for the global cannabis industry, is increasingly becoming a vital platform for recognizing and amplifying the contributions of women who are driving diversity, innovation, and equity across the sector. This year’s event continues to highlight the significant strides women are making, from pioneering brands and…

Read More

DEA Rescheduling Update: Cannabis Process Stalled Amid Political Crosscurrents and Safety Debates

WASHINGTON D.C. – The highly anticipated process to potentially reclassify cannabis from a Schedule I to a Schedule III controlled substance remains in a state of flux, with the Drug Enforcement Administration (DEA) confirming that key appeal processes are still pending. This development comes as a flurry of commentary and action from political figures, industry…

Read More